Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications
IgA Nephropathy: An Overview of the Clinical Trials.
Journal: Kidney medicine
Published: October 06, 2025
In brief: Embryotoxicity REMS removal for endothelin receptor antagonists.
Journal: The Medical letter on drugs and therapeutics
Published: September 09, 2025
Successful targeting of the alternative complement cascade with iptacopan for the treatment of IgA nephropathy: a case report.
Journal: Swiss medical weekly
Published: August 14, 2025
Sparsentan: a dual endothelin and angiotensin II receptor antagonist approved for IgA nephropathy.
Journal: Expert review of clinical pharmacology
Published: July 10, 2025
The disordered structure of sparsentan: energy calculations for competing chain conformations.
Journal: Acta crystallographica. Section C, Structural chemistry
Published: June 17, 2025
CARI Guidelines Commentary on the KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases.
Journal: Nephrology (Carlton, Vic.)
Published: June 02, 2025
Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Journal: The Cochrane database of systematic reviews
Published: May 08, 2025
Framework for precision medicine in focal segmental glomerulosclerosis: Translation of sparsentan-responsive genes in a rat model to kidney disease associated proteins in biofluids.
Journal: medRxiv : the preprint server for health sciences
Published: March 10, 2025
The Rapidly Changing Treatment Landscape of IgA Nephropathy.
Journal: Seminars in nephrology
Published: March 08, 2025
Safety of Drugs in Breastfeeding Women With CKD.
Journal: Kidney international reports
Published: March 06, 2025
Real-world assessment of sparsentan's drug safety framework.
Journal: Renal failure
Published: February 20, 2025
Last Updated: 10/31/2025